About
Taldeki develops biomolecular recognition technology using Metallobodies®, a hybrid mimetic antigen platform that enables rapid, specific, and multiplex detection of antibodies and biomarkers for diagnostics and therapeutic applications.
Explore Taldeki's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.